Volume 25, Number 8—August 2019
Research
Cross-Protection of Dengue Virus Infection against Congenital Zika Syndrome, Northeastern Brazil
Figure 4

Figure 4. Dengue virus prevalence and neutralization among participants in case–control study of cross-protection of dengue virus infection against congenital Zika syndrome, northeastern Brazil. A) Serotype-specific DENV seroprevalence in cases and controls. Statistical significance was calculated by χ2 test. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. B) Multitypic DENV neutralization in cases and controls. Statistical significance for the numbers of neutralized DENV serotypes was calculated by using the Mann–Whitney U test. ***p = 0.0004. C) Multitypic DENV neutralization in cases and controls in different age groups. DENV, dengue virus.
1These authors contributed equally to this article.
Page created: July 16, 2019
Page updated: July 16, 2019
Page reviewed: July 16, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.